Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
about
Calcium and Magnesium for Oxaliplatin-Induced Neurotoxicity: Issues in Study Design, Measurement, and AnalysisCancer-treatment-induced neurotoxicity--focus on newer treatmentsAmerican Cancer Society Colorectal Cancer Survivorship Care GuidelinesAnimal models of peripheral neuropathiesAntineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicityModeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cellsAAPT Diagnostic Criteria for Chronic Cancer Pain ConditionsIdentifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics TechnologyCorrespondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.Intravenous Lidocaine: Old-School Drug, New Purpose-Reduction of Intractable Pain in Patients with Chemotherapy Induced Peripheral NeuropathyBortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve.Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study.Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).Herbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients.A strategy for integrating essential three-dimensional microphysiological systems of human organs for realistic anticancer drug screening.Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trialSerotonergic mechanism of the relieving effect of bee venom acupuncture on oxaliplatin-induced neuropathic cold allodynia in rats.Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire.Platinum-induced neurotoxicity and preventive strategies: past, present, and futureCalcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?New tools for the quantitative assessment of prodrug delivery and neurotoxicity.The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis.Dose delivered to the lumbosacral plexus from high-dose-rate brachytherapy for cervical cancer.Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.Paclitaxel causes degeneration of both central and peripheral axon branches of dorsal root ganglia in miceCR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats.Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment ScaleThe impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer.Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma.Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy.Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral Neuropathy.Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601A TRPA1 antagonist reverts oxaliplatin-induced neuropathic pain.Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic Severity.DNA damage response in peripheral nervous system: coping with cancer therapy-induced DNA lesionsPotential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies.Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesicsInhibition of the human proteasome by imidazoline scaffolds.Clinical study on the prevention of oxaliplatin-induced neurotoxicity with guilongtongluofang: results of a randomized, double-blind, placebo-controlled trial.
P2860
Q26777879-8EBE6BFE-C727-4662-B03C-7057F7327D3AQ26782604-CDC2568B-06DC-416F-B09A-2A4EC812535EQ26782671-4413DEA9-F1AF-4325-AE56-2D8F8C37D090Q27028046-832177D2-BCE1-497D-AF3C-8448E049E496Q27305830-87D77BE1-3442-4FAA-866B-3B9D1DF85C8AQ27314983-30F9B86B-851C-4DD3-9E72-4AE29F264D89Q28079708-8D7F978E-AC1D-4A54-A207-3865E768C37EQ28551798-96DDE0C2-6076-4486-95C7-FC0D228ECDAAQ30818191-ED9C8263-4162-41E8-98EC-FEED71FF4F91Q33552212-C107A7B1-CFF4-497F-AC89-E5DF03480E87Q33617012-224229E1-D640-4897-88B3-D9A558E34F85Q33684190-FC3EF980-E915-4A1B-80B4-BF090298D7FEQ33711444-25F5E795-F742-46BE-9E6A-CE17C993A033Q33770708-1E0DC167-63EF-49A9-8EEB-AC0D12875B77Q34143251-FC8967FB-89BA-4E3A-B74F-92DA524E10C3Q34336573-59BEB7EB-7E81-4868-B9A3-EFD3F652ADB6Q34968046-D54ED70B-87CC-4EF6-BAA2-457132EB7E65Q35248222-5A36A5D6-6192-4731-9DD4-489B00909514Q35345734-C8DF4557-58E7-4A61-A882-1596AE24981CQ35642335-A047B699-ACE1-4335-8D33-63D38E78544FQ35849165-EEA31127-87E4-4C65-920C-9F656453A5A3Q35898310-6F0068C9-B2B6-4D0D-A7AD-AD7834FFD078Q36041265-C915A7AA-0A54-439F-A2B3-1092E477E904Q36057728-F3F5050C-DD8A-4BDD-B67C-E39C6F4499ACQ36073032-D29D9549-E99F-42D9-8172-0AA050AD0B78Q36084704-10B8509D-8889-4E28-AA82-FAECCCCEE9BAQ36117942-23F45E0E-2848-4FA1-88AA-F95CC81661D0Q36156674-1A527C90-9042-42BE-BC11-2B266C55DEA2Q36176588-01009A63-1E43-4E60-ACAB-C88F2CBF651FQ36244607-EEEF3C8B-BCBA-45FE-BCDA-2F062734F930Q36254372-E9C0D9F8-45DD-4F56-AA6C-5DFE8A700765Q36770149-6F129C46-EEA0-4264-9B29-D444AD0B68E7Q36932675-3B98C201-F55B-4C3E-AAC3-158ADDED4561Q36935247-0CDAA753-C140-45C0-99F8-7B07A76C8D49Q36963585-91E17909-EFFA-483F-B192-534944A3F512Q37069571-A421B149-70EC-4B5F-B7D3-25AD659C4257Q37168753-D1BAC789-4208-43C9-B971-41C8860827F8Q37170634-16F74E18-06C0-434C-B12A-1F481FF5BB43Q37351110-C4B47459-BC6F-4F4E-A41A-F3DAE1644B64Q37353630-E03D7B56-8645-4122-9056-B4BF8C1EC9FB
P2860
Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
@en
Chemotherapy-induced peripheral neurotoxicity
@nl
type
label
Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
@en
Chemotherapy-induced peripheral neurotoxicity
@nl
prefLabel
Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
@en
Chemotherapy-induced peripheral neurotoxicity
@nl
P1476
Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
@en
P2093
Andreas A Argyriou
Paola Marmiroli
P356
10.1016/J.CRITREVONC.2011.04.012
P577
2011-09-10T00:00:00Z